<?xml version="1.0" encoding="UTF-8"?>
<item>
    <rel_title>Therapeutic Application of Chloroquine in Clinical Trials for COVID-19</rel_title>
    <rel_doi>10.1101/2020.03.22.20040964</rel_doi>
    <rel_link>http://medrxiv.org/cgi/content/short/2020.03.22.20040964</rel_link>
    <rel_abs>The novel corona virus disease -2019 (COVID-19) pandemic has caused a massive global public health havoc. Recent clinical trials carried out in China has found a promising therapeutic application of chloroquine and hydroxychloroquine for COVID-19. This study meticulously evaluated the various dosages of chloroquine and hydroxychloroquine utilized in clinical trials registered in Chinese and US clinical trial registries for the treatment of pneumonia caused by SARS-CoV-2.</rel_abs>
    <rel_authors>Rana, D. R.; Dulal, S.</rel_authors>
    <rel_date>2020-03-27</rel_date>
    <rel_site>medrxiv</rel_site>
</item>